National Cancer Institute; Notice of Meeting, 23425 [E9-11585]
Download as PDF
<![CDATA[
mstockstill on PROD1PC66 with NOTICES
Federal Register / Vol. 74, No. 95 / Tuesday, May 19, 2009 / Notices
Branch, National Institute on Aging, Gateway
Bldg., 2c212, 7201 Wisconsin Avenue,
Bethesda, MD 20814, 301–402–7701,
nakhaib@nia.nih.gov.
Name of Committee: National Institute on
Aging Special Emphasis Panel; Dietary
Restriction Effect in Population.
Date: June 30, 2009.
Time: 12 p.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institute on Aging,
Gateway Building, 7201 Wisconsin Avenue,
2C212, Bethesda, MD 20814, (Telephone
Conference Call).
Contact Person: Bita Nakhai, PhD,
Scientific Review Officer, Scientific Review
Branch, National Institute on Aging, Gateway
Bldg., 2c212, 7201 Wisconsin Avenue,
Bethesda, MD 20814, 301–402–7701,
nakhaib@nia.nih.gov.
Name of Committee: National Institute on
Aging Special Emphasis Panel; Health,
Aging, and Behavioral Economics.
Date: June 30, 2009.
Time: 12 p.m. to 4 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institute on Aging,
Gateway Building, 7201 Wisconsin Avenue,
2C212, Bethesda, MD 20814, (Telephone
Conference Call).
Contact Person: Rebecca J. Ferrell, PhD,
Scientific Review Officer, National Institute
on Aging, Gateway Building 2c212, 7201
Wisconsin Avenue, Bethesda, MD 20814,
301–402–7703, ferrellrj@mail.nih.gov.
Name of Committee: National Institute on
Aging Special Emphasis Panel; Nutrient
Signaling I.
Date: July 10, 2009.
Time: 9 a.m. to 1 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institute on Aging,
Gateway Building, 7201 Wisconsin Avenue,
2C212, Bethesda, MD 20814, (Telephone
Conference Call).
Contact Person: Bita Nakhai, PhD,
Scientific Review Officer, Scientific Review
Branch, National Institute on Aging, Gateway
Bldg., 2c212, 7201 Wisconsin Avenue,
Bethesda, MD 20814, 301–402–7701,
nakhaib@nia.nih.gov.
Name of Committee: National Institute on
Aging Special Emphasis Panel; Maturing
Heart.
Date: July 23, 2009.
Time: 12 p.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institute on Aging,
Gateway Building, 7201 Wisconsin Avenue,
2C212, Bethesda, MD 20814, (Telephone
Conference Call).
Contact Person: Bita Nakhai, PhD,
Scientific Review Officer, Scientific Review
Branch, National Institute on Aging, Gateway
Bldg., 2c212, 7201 Wisconsin Avenue,
Bethesda, MD 20814, 301–402–7701,
nakhaib@nia.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.866, Aging Research,
National Institutes of Health, HHS)
VerDate Nov<24>2008
16:48 May 18, 2009
Jkt 217001
Dated: May 12, 2009.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. E9–11586 Filed 5–18–09; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
23425
Research; 93.397, Cancer Centers Support;
93.398, Cancer Research Manpower; 93.399,
Cancer Control, National Institutes of Health,
HHS)
Dated: May 12, 2009.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. E9–11585 Filed 5–18–09; 8:45 am]
BILLING CODE 4140–01–P
National Institutes of Health
National Cancer Institute; Notice of
Meeting
Pursuant to section 10(a) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of a meeting of the
National Cancer Institute Clinical Trials
and Translational Research Advisory
Committee. The meeting will be open to
the public, with attendance limited to
space available. Individuals who plan to
attend and need special assistance, such
as sign language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
Name of Committee: National Cancer
Institute Clinical Trials and Translational
Research Advisory Committee.
Date: July 15, 2009.
Time: 8 a.m. to 5 p.m.
Agenda: Update on the progress of the
implementation of the Clinical Trials
Working Group and the Translational
Research Working Group Reports.
Place: National Institutes of Health,
Building 31, 6th Floor, C–Wing, 31 Center
Drive, Conference Room 10, Bethesda, MD
20892.
Contact Person: Sheila A. Prindiville, MD,
Director, Coordinating Center for Clinical
Trials, Office of the Director, National Cancer
Institute, National Institutes of Health, 6120
Executive Blvd., 3rd Floor Suite, Bethesda,
MD 20892, 301–451–5048,
prindivs@mail.nih.gov.
Any interested person may file written
comments with the committee by forwarding
the statement to the Contact Person listed on
this notice. The statement should include the
name, address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
In the interest of security, NIH has
instituted stringent procedures for entrance
onto the NIH campus. All visitor vehicles,
including taxicabs, hotel, and airport shuttles
will be inspected before being allowed on
campus. Visitors will be asked to show one
form of identification (for example, a
government-issued photo ID, driver’s license,
or passport) and to state the purpose of their
visit.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.392, Cancer Construction;
93.393, Cancer Cause and Prevention
Research; 93.394, Cancer Detection and
Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology
PO 00000
Frm 00037
Fmt 4703
Sfmt 4703
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Neurological
Disorders and Stroke; Notice of Closed
Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Neurological Disorders and Stroke Special
Emphasis Panel, Epilepsy Clinical Trials.
Date: June 1, 2009.
Time: 3 p.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Neuroscience Center, 6001 Executive
Boulevard, Rockville, MD 20852. (Telephone
Conference Call.)
Contact Person: William C. Benzing, PhD,
Scientific Review Administrator, Scientific
Review Branch, Division of Extramural
Research, NINDS/NIH/DHHS/Neuroscience
Center, 6001 Executive Boulevard, Suite
3204, MSC 9529, Bethesda, MD 20892. (301)
496–0660. benzingw@mail.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
Name of Committee: National Institute of
Neurological Disorders and Stroke Special
Emphasis Panel, Stroke SEP.
Date: June 2, 2009.
Time: 1 p.m. to 3 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Neuroscience Center, 6001 Executive
Boulevard, Rockville, MD 20852. (Telephone
Conference Call.)
Contact Person: Shanta Rajaram, PhD,
Scientific Review Administrator, Scientific
E:\FR\FM\19MYN1.SGM
19MYN1
]]>Agencies
[Federal Register Volume 74, Number 95 (Tuesday, May 19, 2009)]
[Notices]
[Page 23425]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E9-11585]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of Meeting
Pursuant to section 10(a) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of a meeting of the
National Cancer Institute Clinical Trials and Translational Research
Advisory Committee. The meeting will be open to the public, with
attendance limited to space available. Individuals who plan to attend
and need special assistance, such as sign language interpretation or
other reasonable accommodations, should notify the Contact Person
listed below in advance of the meeting.
Name of Committee: National Cancer Institute Clinical Trials and
Translational Research Advisory Committee.
Date: July 15, 2009.
Time: 8 a.m. to 5 p.m.
Agenda: Update on the progress of the implementation of the
Clinical Trials Working Group and the Translational Research Working
Group Reports.
Place: National Institutes of Health, Building 31, 6th Floor, C-
Wing, 31 Center Drive, Conference Room 10, Bethesda, MD 20892.
Contact Person: Sheila A. Prindiville, MD, Director,
Coordinating Center for Clinical Trials, Office of the Director,
National Cancer Institute, National Institutes of Health, 6120
Executive Blvd., 3rd Floor Suite, Bethesda, MD 20892, 301-451-5048,
prindivs@mail.nih.gov.
Any interested person may file written comments with the
committee by forwarding the statement to the Contact Person listed
on this notice. The statement should include the name, address,
telephone number and when applicable, the business or professional
affiliation of the interested person.
In the interest of security, NIH has instituted stringent
procedures for entrance onto the NIH campus. All visitor vehicles,
including taxicabs, hotel, and airport shuttles will be inspected
before being allowed on campus. Visitors will be asked to show one
form of identification (for example, a government-issued photo ID,
driver's license, or passport) and to state the purpose of their
visit.
(Catalogue of Federal Domestic Assistance Program Nos. 93.392,
Cancer Construction; 93.393, Cancer Cause and Prevention Research;
93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer
Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer
Control, National Institutes of Health, HHS)
Dated: May 12, 2009.
Jennifer Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. E9-11585 Filed 5-18-09; 8:45 am]
BILLING CODE 4140-01-P
